Compliance services

Clinical R&D
MFG
Risk-Based Compliance
Commercial

Sales & Marketing
Government Programs

Contracts

CalcPartner & ClaimsPartner
Assessment & Audit
COT & PHS Validation

PCX

Features

Drug companies that do not have a Compliance Program in place, may soon pay a very high price. Download the white paper,  Building a Compliance Program.

PharmaComplianceXchange (PCX)

EVERGREEN Compliance.

The concept of “commercial compliance” in U.S. pharmaceutical manufacturing has evolved very quickly over the past several years -- as seen by increased regulatory requirements and government scrutiny -- and is a required component of a company’s corporate compliance program. A commercial compliance program should start with a compliance infrastructure that aligns to guidance developed by the Office of Inspector General (OIG), and also includes well-documented policies and procedures at the business level.

programs that thrive in all regulatory climates,
THROUGH all business seasons

CIS' experts have thorough knowledge and understanding of OIG and U.S. FDA regulations and guidelines, as well as industry practices and related state laws and regulations. We work with clients to develop and/or evaluate business processes and protocols to ensure that they support "evergreen" compliance, that is, a program that will remain compliant throughout the year in spite of legislative changes, changes in business process, or changes in business models.

Read more about how CIS can assist you in developing and maintaining your compliance program.